Trials / Completed
CompletedNCT05026437
CASUS vs. APACHE II in Predicting Mortality After Coronary Artery Bypass Grafting
The Value of CASUS vs. APACHE II in Predicting Mortality Among Patients Undergoing Coronary Artery Bypass Grafting
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 204 (actual)
- Sponsor
- Antalya Training and Research Hospital · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study seeks to determine the value of CASUS in predicting mortality as compared with APACHE II scoring system among patients undergoing coronary artery bypass grafting.
Detailed description
Patients undergoing coronary artery bypass grafting will prospectively studied after the admission to the cardiac intensive care unit. Data on the preoperative condition, intraoperative parameters, and postoperative course will collected. CASUS and APACHE II scores will calculated on the first postoperative day. Clinical outcomes are defined as 7-day mortality, 30-day mortality and morbidity. Morbidity includes variables such as length of stay in the cardiac surgical intensive care unit and in the hospital.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Cardiac surgery score and APACHE II scoring | Cardiac surgery score and APACHE II will calculated on the first postoperative day. |
Timeline
- Start date
- 2019-01-02
- Primary completion
- 2019-03-10
- Completion
- 2019-04-10
- First posted
- 2021-08-30
- Last updated
- 2021-08-30
Locations
2 sites across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT05026437. Inclusion in this directory is not an endorsement.